FertiPro N.V. HSA-containing ART media - Procedural steps and scientific information after initial consultation

Orphan designation: Expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue (darvadstrocel) Treatment of anal fistula, 08/10/2009 Withdrawn

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 7: Submission of other post-authorisation data

Report - Industry stakeholders and EU network experts surveys on early engagement fostering innovation

Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Date of authorisation: 16/12/1998, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 30, Status: Authorised